Kyverna's Phase 2 trial of Miv-Cel meets key endpoints, shares up over 30% pre-market

Monday, Dec 15, 2025 6:38 am ET1min read

Kyverna's Phase 2 trial of Miv-Cel meets key endpoints, shares up over 30% pre-market

Comments



Add a public comment...
No comments

No comments yet